drugset / Trial / NCT00963365
AZD6765 Oral Single Ascending Dose/Multiple Ascending Dose (SAD/MAD)
RandomizedCrossoverSingle-blind
Summary
The purpose of this study is to determine the safety of AZD6765 when given in single and multiple oral doses and to compare an oral and intravenous (IV) formulation of AZD6765 to placebo.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-02
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | lanicemine | Small molecule | — | Oral |
Indications
No indication recorded.